Premiere Episode: Glaucoma Case Files

In a new series captured at NYU Langone Health, Joseph F. Panarelli, MD; Manjool Shah, MD; and Arsham Sheybani, MD, convene in an OR to discuss real-time surgical care. Dr. Panarelli describes a patient who had an IOP spike after LASIK 10 years ago and whose pressure has since been controlled with topical therapy. The patient recently experienced a significant IOP elevation after uncomplicated routine phacoemulsification. The three surgeons discuss the options for approaching this type of case and how to reduce the likelihood and severity of postoperative pressure spikes.

Meeting Updates

  • AGS Annual Meeting | February 29–March 3; Huntington Beach, California
  • ASCRS Annual Meeting | April 5–8; Boston
  • YoungMD Connect Live | April 19–21; Austin, Texas
  • 16th European Glaucoma Society Congress | June 1–4; Dublin
  • Glaucoma Research Foundation Patient Summit | June 28–29; Philadelphia
  • ESCRS Annual Meeting | September 6–10; Barcelona, Spain
  • AAO Annual Meeting | October 18–21; Chicago
  • Interventional Glaucoma Consortium | November 15–17; Salt Lake City
  • IGC Fellows Program | November 15; Salt Lake City

Survey Says: Which Treatment Next?

On this episode of Survey Says, a special edition of GT: The Podcast, I. Paul Singh, MD, is joined by guests Zarmeena Vendal, MD, and Joseph F. Panarelli, MD. They share their perspectives on the evolution of glaucoma care in recent decades and how these changes have affected their decision-making process. Later, the guests weigh in on the case at hand and share their preferred treatment options for the patient. Then, they review how their colleagues would proceed, based on the results of a social media poll of GT’s audience.

Elements of Subjectivity

“[Patient-reported outcome measures] are often criticized as being subjective. I would encourage people to understand that many of the outcome assessments we do in clinical practice—such as visual acuity and visual field testing—have an element of subjectivity based on patient motivation and assessor engagement, but we still use that information to make decisions. And so, we shouldn’t discount so readily the structured assessment of patients reporting how they feel and function.” —Michelle E. Tarver, MD, PhD, FDA Deputy Center Director, Chief Transformation Officer, Center for Devices and Radiological Health, on overcoming barriers to the use of patient-reported outcome measures in ophthalmology: bit.ly/3Sr8oJc